Nationally Recognized Guidance for opioid settlement funds

Principles for the Use of Funds From the Opioid Litigation

Developed by a coalition of organizations across the spectrum of the substance use field including physicians, addiction medicine specialists, recovery, treatment, and harm reduction. The Principles for the Use of Funds From the Opioid Litigation provide planning and process level guidance for state and local policymakers on how to effectively spend money from the opioid settlements.

Updates

Keep up with what is happening with opioid settlement outcomes, opioid settlement tracking, related legislation, and state and local opioid settlement implementation strategies.

In the Media

Why all the buzz about The Principles? See how The Opioid Settlement Principles have been shared nationwide.

Explore the Science

Explore what emerging science is saying about substance use intervention strategies.

Implementing Opioid Settlement Guidance

Tools and Resources to assist in Implementing the Principles

For specific guidance for state and local jurisdictions on how to spend their portion of the opioid litigation dollars, these supplemental documents can help assess and guide your opioid settlement planning process and spending allocations.

Implementation Tools

Implications for the Opioid Overdose Crisis

Over 500,000 people have died from opioid overdoses since 1999. Unfortunately, the crisis has worsened during the COVID-19 pandemic. An estimated 106,000 people died from opioid overdoses in 2020, more than in any other year. Fortunately, states and local jurisdictions will soon have additional money from the opioid settlements to invest in evidence-based solutions as a result of litigation brought against opioid manufactures, distributors and dispensers.

Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims

The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.

Statement from Public Health Experts on Announcement of Opioid Settlement

Reaction to the announcement of the $26 billion settlement deal between a group of state attorneys general and Cardinal Health, AmerisourceBergen, McKesson, and Johnson & Johnson.

COVID Dollars, Best Practices Arm Communities with New Weapons Against Drug-Overdose Scourge

Federal spending to address substance use disorders and mental illness is increasing by around 25%. It is a once-in-a-generation opportunity to improve our response to substance use disorders, but it also challenges us to spend the money wisely.